Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03CJL
|
||||
| Former ID |
DAP000412
|
||||
| Drug Name |
Droperidol
|
||||
| Synonyms |
DHBP; Dehidrobenzperidol; Dehydrobenzoperidol; Dehydrobenzperidol; Deidrobenzperidolo; Dihidrobenzperidol; Dridol; Droleptan; Droperidolo; Droperidolum; Halkan; Inappin; Inapsin; Inapsine; Innovan; Inopsin; Inoval; Leptanal; Leptofen; Properidol; Sintodril; Sintosian; Thalamanol; Thalamonal; Vetkalm; Component of Innovar; Droperidolo [DCIT]; Janssen Brand of Droperidol; Kern Brand of Droperidol; Taylor Brand of Droperidol; R 4749; R4749; Dridol (TN); Droleptan (TN); Droperidolum [INN-Latin]; Dropletan (TN); HS-0065; INAPSINE (TN); Inapsine (TN); Innovar-vet; McN-JR 4749; R-4749; Ina.psi.n; Ina.psi.ne; Ino.psi.n; McN-JR-4749; Droperidol (JP15/USP/INN); Droperidol [USAN:INN:BAN:JAN]; Luorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone; 1-(1-(3-(p-Fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone; 1-(1-(4-(4-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridinyl)-1,3-dihydro-2H-benzimidazol-2-one; 1-(1-(4-(p-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone; 1-1-[3-(p-Fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl-2-benzimidazolinone; 1-[1-[3-(p-Fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone; 1-[1-[4-(p-F; 1-[1-[4-(p-Fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone; 1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydropyridin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one; 2-Benzimidazolinone, 1-[1-[3-(p-fluorobenz; 3-[1-[4-(4-fluorophenyl)-4-oxobutyl]-3,6-dihydro-2H-pyridin-4-yl]-1H-benzimidazol-2-one
|
||||
| Drug Type |
Small molecular drug
|
||||
| Therapeutic Class |
Antipsychotic Agents
|
||||
| Company |
Janssen Pharmaceutica
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C22H22FN3O2
|
||||
| InChI |
InChI=1S/C22H22FN3O2/c23-17-9-7-16(8-10-17)21(27)6-3-13-25-14-11-18(12-15-25)26-20-5-2-1-4-19(20)24-22(26)28/h1-2,4-5,7-11H,3,6,12-15H2,(H,24,28)
|
||||
| InChIKey |
RMEDXOLNCUSCGS-UHFFFAOYSA-N
|
||||
| CAS Number |
CAS 548-73-2
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
223506, 562873, 855921, 7709467, 7847374, 7979136, 7979613, 8149690, 8152018, 10321660, 10526647, 11112409, 11335278, 11360517, 11364114, 11366676, 11369238, 11372451, 11373813, 11377400, 11461489, 11466388, 11467508, 11485108, 11486116, 11489202, 11491241, 11492222, 11495034, 14780048, 24278357, 26612144, 26680496, 26719691, 26748461, 26748462, 29222310, 46386863, 46505291, 47216634, 47290988, 47290989, 47290990, 47736310, 47736311, 48334331, 48415932, 49698455, 49883200, 50100428
|
||||
| SuperDrug ATC ID |
N05AD08
|
||||
| SuperDrug CAS ID |
cas=000548732
|
||||
| Target and Pathway | |||||
| Target(s) | D(2) dopamine receptor | Target Info | Binder | [535656] | |
| References | |||||
| Ref 538243 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 072123. | ||||
| Ref 542182 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7172). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.